FTC eyes crackdown on improper drug patents in FDA’s Orange Book fkansteiner Thu, 09/07/2023 – 15:31 More: FTC eyes crackdown on improper drug patents in FDA's Orange Book Source: fierce
read morePatent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts kdunleavy Thu, 09/07/2023 – 14:46 More: Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts Source: fierce
read moreRoche hits FDA delay with subcutaneous version of Tecentriq amid manufacturing process changes aliu Thu, 09/07/2023 – 14:27 More: Roche hits FDA delay with subcutaneous version of Tecentriq amid manufacturing process changes Source: fierce
read moreGSK could face disruptions at 2 sites from possible UK contractor strike, union says fkansteiner Thu, 09/07/2023 – 11:18 More: GSK could face disruptions at 2 sites from possible UK contractor strike, union says Source: fierce
read moreBMS sought bogus patents, filed sham lawsuits and more to protect Pomalyst, lawsuit says zbecker Thu, 09/07/2023 – 10:53 More: BMS sought bogus patents, filed sham lawsuits and more to protect Pomalyst, lawsuit says Source: fierce
read moreJ&J dumps high-dose Opsumit trial upon failure in rare type of pulmonary hypertension aliu Thu, 09/07/2023 – 10:47 More: J&J dumps high-dose Opsumit trial upon failure in rare type of pulmonary hypertension Source: fierce
read more© 1994 - 2023 B.M. Pharmaceuticals